ZOMDF Sets Annual Meeting for June 10, 2026; Key Votes on Directors, Auditor

Zomedica Corp. filed a definitive proxy statement (DEF 14A) for its Annual Meeting of Shareholders to be held virtually on June 10, 2026. Shareholders will vote on the election of eight director nominees, the ratification of Grant Thornton LLP as the independent registered public accounting firm for 2026, an advisory vote on executive compensation, and an amendment to the Company's By-Laws concerning quorum requirements for adjourned meetings. The record date for shareholders entitled to vote is April 21, 2026.